BIOMAGNETICS DIAGNOSTICS CORPORATION ( BMGP )
Zhuhai Oil Energy Science and Technology Ltd
A Subsidary of BMGP
Zhuhai Oil Energy Science and Technology Ltd. operates as an inventor and producer of unique gasoline and diesel biofuel blends. The company is based in Guangdong Province, China. As of September 13, 2010, Zhuhai Oil Energy Science and Technology Ltd. operates as a subsidiary of Biomagnetics Diagnostics Corp.
BioFuel Conference Link
-The FDA released a report saying they needed quick detection devices to screen alot of people quickly.
-IOBS could be a very effective device in helping the FDA secure our airports and prevent the spread of Ebola!
"On September 22, 2006, then-Secretary of the Department of Homeland Security (DHS), Michael Chertoff, determined, pursuant to section 319F-2 of the Public Health Service (PHS) Act (42 U.S.C. § 247d-6b), that the Ebola virus presents a material threat against the United States population sufficient to affect national security. Pursuant to section 564(b)(1) of the Act (21 U.S.C. § 360bbb-3(b)(1)), and on the basis of such determination, the Secretary of HHS declared on August 5, 2014, that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection of Ebola virus, subject to the terms of any authorization issued under 21 U.S.C. § 360bbb-3(a)."
-Biomagnetics Diagnostics Corp. (BMGP) has developed two products to assist in early detection/screening of a large amount of patients in a short amount of time.
-Integrity Optical Biosensor (IOBS) are ideal for airports with untrained personnel for screening large amounts of pateints.
-With the following unit, minimal training is required to follow the easy to use method. Near 100% accuracy in minutes, instead of days or weeks at a lab.
"These devices are specifically designed to be battery operated and ultra-portable, allowing for the rapid detection of various viral and bacterial pathogens by relatively untrained personnel outside of the laboratory setting."
-High Throughput Screening - Magnetic Testing Platform (HTS-MTP) is a more advanced test than the portable IOBS device to quickly detect specific antibodies quicker than traditional testing.
"Biomagnetics Diagnostics Corp. has designed a revolutionary system of diagnostics. Our High Throughput Screening – Magnetic Testing Platform (HTS-MTP) is designed to detect both qualitative (chemical identification of the elements present in a substance) and quantitative(number of specific elements in a substance) results from a single test."
"Most testing conducted in the United States today are screening assays (limited to the detection of antibodies), and are largely for detection purposes only. These tests are limited because they can only detect the presence of antibodies after a minimum infection time of two to six weeks. The Western Blot Test, the most widely used confirmatory test, again tests only for antibodies. The HTS-MTP system is designed to detect the virus (not the antibodies the human body produces to react to the virus) in a fraction of the time--72 to 96 hours. All with near 100% accuracy."
Share Structure: LOW FLOAT
8864 Greenback Lane, Suite E
Orangevale, CA 95662
(916) 987-7922 (fax)
Clayton M. Hardman, Founder, President & CEO
Dr. Hai Shiene Chen, President and founder of ACGT DNA Technologies Corporation. Stem Cell and Genetic Engineering Advisor, Chinese Corporate Development Consultant
Dr. Jose Manuel Lopez Portillo, , Director Strategic Alliances & Govn't Affairs Mexico:
Rear Admiral Udomporn Sompongse (ret.), Director Strategic Alliances and Government Affairs Thailand:
Sanjay Mishra, Ph.D., Physics, Advisor:
Kuldip Sra, Ph.D., Chemistry, Advisor:
Jaspal Singh Mahal, MS, Microbiology, Advisor:
Ninlawan (Pichayayothin) Petcharaburanin, Ph.D., Advisor:
Last update 10/14/2014
All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.